143 related articles for article (PubMed ID: 36127617)
1. Very-Long-Chain Fatty Acids Quantification by Gas-Chromatography Mass Spectrometry.
Scott AI
Methods Mol Biol; 2022; 2546():501-508. PubMed ID: 36127617
[TBL] [Abstract][Full Text] [Related]
2. Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
De Biase I; Pasquali M
Methods Mol Biol; 2022; 2546():509-521. PubMed ID: 36127618
[TBL] [Abstract][Full Text] [Related]
3. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
[TBL] [Abstract][Full Text] [Related]
4. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.
Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N
Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346
[TBL] [Abstract][Full Text] [Related]
5. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
[TBL] [Abstract][Full Text] [Related]
6. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
7. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
[TBL] [Abstract][Full Text] [Related]
8. Ratios for very-long-chain fatty acids in plasma of subjects with peroxisomal disorders, as determined by HPLC and validated by gas chromatography-mass spectrometry.
Hall NA; Lynes GW; Hjelm NM
Clin Chem; 1988 Jun; 34(6):1041-5. PubMed ID: 2454167
[TBL] [Abstract][Full Text] [Related]
9. An improved method for quantification of very long chain fatty acids in plasma.
Vallance H; Applegarth D
Clin Biochem; 1994 Jun; 27(3):183-6. PubMed ID: 7522996
[TBL] [Abstract][Full Text] [Related]
10. Measurement of plasma pristanic, phytanic and very long chain fatty acids by liquid chromatography-electrospray tandem mass spectrometry for the diagnosis of peroxisomal disorders.
Johnson DW; Trinh MU; Oe T
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(1):159-62. PubMed ID: 14630371
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
Poulos A; Sharp P; Fellenberg AJ; Johnson DW
Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
[TBL] [Abstract][Full Text] [Related]
12. Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry.
Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH
J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):281-7. PubMed ID: 9746242
[TBL] [Abstract][Full Text] [Related]
13. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders.
Morales-Romero B; González de Aledo-Castillo JM; Fernández Sierra C; Martínez Carreira C; Zaragoza Bonet C; Fernández Bonifacio R; Caro Miró MA; Argudo-Ramírez A; López Galera RM; García-Villoria J
J Lipid Res; 2024 Mar; 65(3):100516. PubMed ID: 38320654
[TBL] [Abstract][Full Text] [Related]
14. Brain Lipotoxicity of Phytanic Acid and Very Long-chain Fatty Acids. Harmful Cellular/Mitochondrial Activities in Refsum Disease and X-Linked Adrenoleukodystrophy.
Schönfeld P; Reiser G
Aging Dis; 2016 Mar; 7(2):136-49. PubMed ID: 27114847
[TBL] [Abstract][Full Text] [Related]
15. Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders.
Subhashini P; Jaya Krishna S; Usha Rani G; Sushma Chander N; Maheshwar Reddy G; Naushad SM
J Biochem; 2019 Jan; 165(1):67-73. PubMed ID: 30295825
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of peroxisomal disorders by analysis of phytanic and pristanic acids in stored blood spots collected at neonatal screening.
ten Brink HJ; van den Heuvel CM; Christensen E; Largillière C; Jakobs C
Clin Chem; 1993 Sep; 39(9):1904-6. PubMed ID: 8375069
[TBL] [Abstract][Full Text] [Related]
17. Measurement of very long-chain fatty acids, phytanic and pristanic acid in plasma and cultured fibroblasts by gas chromatography.
Dacremont G; Cocquyt G; Vincent G
J Inherit Metab Dis; 1995; 18 Suppl 1():76-83. PubMed ID: 9053557
[TBL] [Abstract][Full Text] [Related]
18. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
[TBL] [Abstract][Full Text] [Related]
19. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
[TBL] [Abstract][Full Text] [Related]
20. Investigational methods for peroxisomal disorders.
Steinberg S; Jones R; Tiffany C; Moser A
Curr Protoc Hum Genet; 2008 Jul; Chapter 17():Unit 17.6. PubMed ID: 18633975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
